These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease. Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A. J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794 [Abstract] [Full Text] [Related]
9. Diagnosis and management of Wilson's disease: results of a single center experience. Medici V, Trevisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S, Martines D, Irato P, Sturniolo GC. J Clin Gastroenterol; 2006 Feb; 40(10):936-41. PubMed ID: 17063115 [Abstract] [Full Text] [Related]
10. Membranoproliferative glomerulonephritis in a patient with Wilson's disease. Ozçakar ZB, Ekim M, Ensari A, Kuloglu Z, Yüksel S, Acar B, Kirsaçlioglu C, Kansu A, Yalçinkaya F, Girgin N. J Nephrol; 2006 Feb; 19(6):831-3. PubMed ID: 17173260 [Abstract] [Full Text] [Related]
14. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A, Curiel B, Berkowitz D, Levine A, Sack J, Lorberboym M. J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823 [Abstract] [Full Text] [Related]